A review on hyperthyroidism: Thyrotoxicosis under surveillance

Pakistan Journal of Biological Sciences

Volumn 13, Issue 22, 2010, Pages 1066-1076

  Mansourian, Azad Reza ^a  

^a GOLESTAN UNIVERSITY   (Iran)

Author keywords

Clinical manifestation; Hyperthyroidism; Laboratory diagnosis; Thyrotoxicosis; Thyroxine

Indexed keywords

EID: 78249277434     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2010.1066.1076     Document Type: Review

References (142)

1. Al-Khafaji, F., M. Wiltshire, D. Fuhrer, G. Mazziotti, M.D. Lewis, P.J. Smith and M. Ludgate, 2005. Biological activity of activating thyrotrophin receptor mutants modulation by iodide. J. Mol. Endocrinol., 34: 209-220.
2. Anderson, N.R., J. J. Lokich, W. V. McDermott Jr., C. Tery and K.R. Falchuk, 1979. Gestational choricarcinoma and thyrotoxicosis. Cancer, 44: 304-306.
3. Becjer, F.O., P.G. Economou and T.B. Schwartz, 1963. The occurrence of carcinoma in hot thyroid nodules report of tow cases. Ann. Intern. Med., 58: 877-882.
4. Becker, C. andC. Cornette, 1971. TSH production rate in non toxic goiter. J. Clin. Endocrinol. Metab., 32: 852-854.
5. Belfiore, A., M.R. Charofalo, D. Giuffnda, F. Runello and S. Filetti et al, 1990. Increased aggressiveness of thyroid cancer in patients with Graves disease. J. Clin. Endocrinol. Metab., 70: 830-835.
6. Benoit, R., B.E. Pearson-Murphy, F. Robert, S. Marcovitz, J. Hardy, G. Tsoukas and R.J. Gardiner, 1980. Hyperthyroidism due to a pituitary TSH secreting tumour with amenorrhoea-galactorrhoea. Clin. Endocrinol, 12: 11-19.
7. Berghout, A., W.M. Wiersing, N.J. Smith and J.L. Touber, 1990. Interrelationship between age, thyroid volume, thyroidnodularity and thyroidfunction in patientswithsporadic non-toxicgoiter. Am. J. Med, 89: 602-608.
8. Berglud, J., U.B. Ericsoon and B. Hallengren, 1996. Increased incidence of thyrotoxicosis in Maimo during the years 1988-1990 as compared to the years 1970-1974. J. Intern. Med., 239: 57-62.
9. Biondi, B., S. Fazio, C. Carella, G. Amato and A. Cittadini et al., 1993. Cardiac effects of longterm thryotropin suppressive therapy with levothyroxine. J. Clin. Endocrinol. Metab., 77: 334-338.
10. Bogazzi, F., L. Bartalena, S. Brogioni, A. Burelli and L. Manetti et al., 1999. Thyroid vascularty and blood flow arenot dependent on serum thyroid hormone levels: Studies in vivo by color flow Dopper sonography. Eur. J. Endocrinol., 140: 452-456.
11. Bogazzi, F., L. Bartalena, M. Gasperi, L.E. Braverman and E. Martono, 2001. The various effects of amiodarone on thyroid function. Thyroid, 11: 511-519.
12. Bransom, C. J., G.H. Talbot, L. Henry and J. Elemenoglou, 1979. Soltary toxic adenoma of the thyroid gland. Br. J. Surg., 66: 590-595.
13. Carayon, P., G. Lefort and B. Nisula, 1980. Interaction of human chorionic gonadotropin and human luteinizing hormone with human thyroid membranes. Endocrinology, 106: 1907-1916.
14. Chanson, P., B.D. Wemtraub and A.G. Harris, 1993. Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas: A follow-up of 52 patients. Ann. Intern. Med., 119: 236-240.
15. Ciccarelli, A., H. Valdes-Socin, J. Parma, S.K. Khoo and J. Schoumans et al., 2004. Thyrotoxic adenoma followed by atypical hyperthyroidism due to sturm ovarii: Clinical and genetic studies. Eur. J. Endocrinol, 150: 431-437.
16. Cole, L.A. and A. Kardana, 1992. Discordant result in human chorionic gonadotropin assays. Clin. Chem., 38: 263-270.
17. Connolly, R.J., G.I. Vidor and J.C. Stewart, 1970. Increase in thyrotoxicosis in endemic goiter area after iodination of bread. Lancet, 1: 500-502.
18. Cooper, D.S., 2003. Hyperthyroidism. Lancet 362: 459-468.
19. Davies, T.F., G.S. Tahaduros, K.J. CattandB.C. Nisula, 1979. Assessment of urinary thyrotropin competing activity in shoriocarcinoma and thyroid disease. J. Clin. Endocrinol. Metab., 49: 353-357.
20. Davies, T.F. and M. Platzer, 1986. hCG induced TSH receptor activation and growth acceleration in FRTL-5 thyroid cells. Endocrinology, 118: 2149-2151.
21. De Bruin, T.W., H. van Barlingen, T.M. van Linde-Sibenius, A.R. van Vuurst de Vries, M. J. Akveld and D.W. Erkelens, 1993. Lipoprotein(a) and apolipoprotein B, plasma concentrations in hypothyroid, euthyroid and hyperthyroid subjects. J. Clin. Endocrinol. Metab., 7: 121-126.
22. Deleu, S., Y. Allory, A. Radulescu, I. Pirson and N. Carraso et al, 2000. Chracterization of autonomous thyroid adenoma: Metabolism gene expression and pathology. Thyroid, 10: 131-140.
23. Derwahl, M., 1996. TSH receptor and Gs alpha gene mutations in the pathogenesis of toxic adenoma a note of caution. J. Clin. Endocrinol. Metab., 81: 2783-2785.
24. Derwahl, M., C. Hamacher, D. Russo, M. Broecker and D. Manole et al., 1996. Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas. J. Clin. Endocrinol. Metab., 81: 1898-1904.
25. Derwahl, M. and H. Studer, 2001. Nodular goiter and goiter nodules where iodine deficiency falls short of explaining the facts. Exp. Clin. Endocrinol. Diabet, 109: 250-260.
26. Dige-Petersen, H. and L. Hummer, 1977. Serum thyrotropin concentration under basal conditional andafter stimulation with thyrotropin-re leasing hormone in idiopathic goiter. J. Clin. Endocrinol. Metab., 44: 1115-1120.
27. Dowling, J.T., S.H. Ingbar, N. Frebkel, 1960. Iodine metabolism in hydatidiform mole and choriocarcinoma. J. Clin. Endocrinol. Metab., 20: 1-12.
28. Dratman, M.B. andJ.T. Grodon, 1996. Thyroid hormones as neurotransimiter. Thyroid, 6: 639-647.
29. Duperz, L., J. Parma, A. Van Sande, J. Allgeier and J. Leclere et al., 1994. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat. Genet., 7: 396-401.
30. Emerson, C.H. andR.D. Utiger, 1972. Hyperthyroidism and excessive thryotropin secretion. N Engl. J. Med., 287: 328-333.
31. Emnch, D., U. Erlenmaier, M. Pohl and H. Lmg, 1993. Deternination of the autonomously functioning volume of the thyroid. Eur. J. Nucl. Med. Mol. Imaging, 20: 410-414.
32. Eyre-Brooke, I.A. and C.H. Talbot, 1982. The treatment of autonomous functioning thyroid nodules. Br. J. Surg., 69: 577-579.
33. Faber, J. and A.M. Gallo, 1994. Changes in bone mass during prolonged sublinical hyperthyroidism due to L thyroxine treatment. Eur. J. Endocrimnol., 130: 350-356.
34. Franklyn, J.A., J. Daykin, J. Bettendge, E.A. Hughes, R. Holder, S.R. Jones and M.C. Sheppard, 1993. Thyroxine replacement therapy andcirculating lipidconcentration Clin. Endocrinol., 38: 453-459.
35. Franklyn, J., J. Betterdige, R. Holder, J. Daykin, J. Lilley and M. Sheppard, 1994. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis. Clin. Endrocinol., 41: 425-432.
36. Fujimoto, Y., A. Oka and S. Nagataki, 1972. Occrrence of papillary carcinoma in hyperfuntioning thyroid nodule. Report of a case. Endocrinol. Jpn, 19: 371-374.
37. Gabril, E.M., E.R. Bergert, C.S. Grant J.A. vanHeerden, G.B. Thompson and J.C. Morris, 1999. Gemlme polymorphism ofcodon 727, of human thyroidstimulating receptor is associated with toxicmultinodular goiter. J. Clin. Endocrinol. Metab., 84: 3328-3335.
38. Galton, V.A., 1968. Abnormalities of thyroid hormone economy in patients with hydtidiform mole. Proceedins of the Program, Annual Meeting of American Thyroid Association, Oct. 10-12, Statler Hilton Hotel, Washington, DC, pp: 35-pp: 35.
39. Gershengorn, M.C. and B.D. Weintraub, 1975. Thyrotropin induced hyperthyroidism caused by selective pituitary resistence to thyroid hormone. J. Clin. Invest., 56: 633-642.
40. Gesundheit, N., P.A. Petrick, M. Nissim, P.A. Dahlberg and J.L. Doppman et al., 1989. Thyrotropin secreting pituitary adenomas: Clinical and biochemical heterogeneity. Case reports and follow-up of 9 patients. Ann. Intern. Med., Ill: 827-835.
41. Glinoer, D. and M. Lemone, 1992. Goiter and pregnancy: A new insight into an old problem. Thyroid, 2: 65-70.
42. Goldstein, R. and I.R. Hart, 1983. Follow-up of solitary autonomous thyroid nodules treated with 1131. N Eng. J. Med., 309: 1473-1476.
43. Gorman, C.A., D.S. Duick, L.B. Woolner and H.W. Wahner, 1978. Transient hyperthyroidism in patients with lymphocytic thyroiditis. Mayo Clin. Proc, 53: 359-365.
44. Guters, A., T. Schonberg, H. Biebermann, H. Krude, H.P. Krohn, H. Dralle and T. Gudermann, 1998. Sever congential hypethyroidism caused by a germ line neo multation in the extracelluar portion of the thyrotropin receptor. J. Clin. Endocrinol. Metab., 83: 1431-1436.
45. Hamburger, J.L, 1975. Solitary autonomously functioning thyroid lesions diagnosis clinical features and pathogenetic consideration. Am. J. Med., 58: 740-748.
46. Hamburger, J.I., 1980. Evolution of toxicity in solitary non toxic autonomously functioning thyroid nodules. J. Clin. Endocrmol. Metab., 50: 1089-1093.
47. Hedberg, C.W., D.B. Fishbein, R.S. Janseen, B. Meyers and J.M. McMillen et al, 1987. An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beaf. N. Engl. J. Med.,316: 993-998.
48. Hershman, J.M. and P. Higgins, 1971. Hydatidiform mole: A cause of clinical hyperthyroidism. N. Engl. J. Med., 284: 573-577.
49. Hershman, J.M., H.Y. Lee, M. Sugawara, C.J. Mirell and X.P. Pang et al, 1988. Human chorionic gonadotropin stimulates iodide uptake adenylate cyclase and deoxyribonucleic acid synthesis in cultured rat thyroid cells. J. Clin. Endocrinol. Metab., 67: 74-79.
50. Hill, S.A., J.M. Falko, C.B. Wilson and W.E. Hunt 1982. Thyrotrophin: Producing pituitary adenomas. J. Neur. Surg., 57: 515-519.
51. Hintze, G., O. Blombach, H. Fink and U. Burkhardt and J. Kobberling, 1999. Risk of iodine-induced thyrotoxicosis after coronary angiography: An investigation in 788 unselected subjects. Eur. J. Endorcrinol., 140: 264-267.
52. Hoermann, R., S.M. Amir and S.H. Ingbar, 1988. Evidence that partially desialylated variants of human chorionic gonadotropin (hCG) are the factors in hCG that inhibit the respone to thyrotropin in human thyroid members. Endocrinology, 123: 1535-1543.
53. Hoermann, R., M. Brocker, M. Grossmann, K. Mann, M. Derwahl, 1994. Interaction of human chorionic gondotropin (hCG) and asialo hCG with recombinant human thyrotropin receptor. J. Clin. Endocrinol. Metab., 78: 933-938.
54. Holzapfel, H.P., D. Fuher, P. Wonerow, G. Weinland, W.A. Scherbaum andR. Paschke, 1997. Identification of constitutively activating somatic thyrotropin receptor mutation in asub-set oftoxicmultinodular goiter. J. Clin. Endocrinol. Metab., 82: 4229-4233.
55. Holtzapfel, H.P., B. Bergner, P. Wonerof andR. Paschke, 2002. Expression of gas proteins and TSH receptor signaling in hyperfunctioning thyroid nodules with TSH receptor mutations. Eur. J. Endocrinol., 147: 109-116.
56. Horst, W., H. Rosier, C. Schneider and A. Labhart, 1967. 306 cases of toxic adenoma: Clinical aspects finidings in radioiodine diagnostics radiochromatography and histology. Results of 1131 and surgical treatment. J.Nucl. Med., 8: 515-528.
57. Karger, S. andD. Fuhrer, 2008. Thyroid storm-thyrotoxic crisis: An Update. Dtsch. Med. Wochenschr., 133: 479-484.
58. Kasagi, K., R. Takeuchi, S. Miyamoto, T. Misaki and D. Inoue et al., 1994. Metastatic thyroid cancer presenting as thyrotoxicosis: Report of three cases. Clin. Endocrinol. (Oxf)., 40: 429-434.
59. Kempers, R.D., M.B. Dockerty, D.L. Hoffman and L.G. Bartholomew, 1970. Struma ovarii-ascitic hypethyroid and asymptomatic syndromes. Am. Int. Med., 72: 883-893.
60. Kenimer, J.G., J.M. Hershman and H.P. Higgins, 1975. The thyrotropin in hydatidiform moles is human chorionic gonadotropin. J. Clin. Endocrinol. Metab., 40: 482-491.
61. Kim, C.S., J.G. Kang, S.J. Lee, S.H. Thm and H.J. Yoo et al., 2009. Relationship of low-density lipoprotein (LDL) particlesize to thyroidfunction status in Koreans. Clin. Endocrmol., 71: 130-136.
62. Kinney, J.S., E.S. Hurwutz, D.B. Fishbein, P.D. Woolf and P.F. Pinsky et al., 1988. Communty outbreak of thyrotoxicosis epidemiology immunogenetic charateristics and long term outcome. Am. J. Med., 84: 10-18.
63. Kirrkegaard, C. and J. Faber, 1998. The role of thyroid hormones in depression. Eur. J. Endocrinol., 138: 1-9.
64. Kock, H., H.V. Kessel, L. Stolte andH.V. Leusden, 1966. Thyroid function in molar pregnancy. J. Clin. Endocrinol. Metab., 26: 1128-1134.
65. Kopp, P., E.T. Kimura, S. Aeschimann, M. Oestreicher, A. Toble, M.F. Fey and H. Studer, 1994. Polyclonal andmonoclonal nodules coexist with human multinodular goiter. J. Clin. Endocrinol. Metab., 79: 134-139.
66. Kopp, P., J. Van Sande, J. Parma, L. Duprez and H. Gerber et at, 1995. Brif report congenital hyperthyroidism caused by a mutation in the thyrotropin receptor gene. N. Engl. J. Med., 332: 150-154.
67. Krohn, K. and R. Paschke, 2002. Somatic mutation in thyroid nodular diseases. Mol. Genet. Metab., 75: 202-208.
68. Kutty, K.M., D.G. Brayant and N.R. Farid, 1978. Seum lipids in hypothyroidism: A re-valution. J. Clin. Endocrinol. Metab., 46: 55-56.
69. Lamberg, B.A., R Pelkonen, A. Gordin, M. Haltia, T. Wahlstrom, A. Paetau and J. Leppaluoto, 1983. Hyperthyroidism and GH-secreting tumour. Acta Endocrinol, 103: 7-14.
70. Lax, S.F., G. Semlitsch, S. Schaure, K. Zatloukal, W. Langsteger, O. Eber and G. Hofler, 1997. Point mutations of the thyrotropin receptor gene in autonomously functioning thyroid gland nodules correlation with clinical finding and morphology. Vern. Dtsch. Ges. Pathol, 81: 145-150.
71. Lee W.Y., I.Y. Suh, E.J. Rhee, J.S. Park, K.C. Sung and S.W. Kim, 2004. Plasma CRP, apolipoprotein A-l,apolipoprotein B andLpa lev els according to thyroid function status. Arch. Med. Res., 35: 540-545.
72. Leger, A.F., J.P. Massin, M.F. Laurent, M. Vincens and M. Auriol etal., 1984. Iodine-induced thyrotoxicosis: Analysis of eighty five consecutive vases. Eur. J.Clin. Invest, 14: 449-455.
73. Liberopoulos, E.N. and M.S. Elisat, 2002. Dyslipidemia in patients with thyroid disorders. Hormones (Athenes), 1: 218-223.
74. Maji, D., 2006. Hyperthyroidism. J. Indian Med. Assoc, 104: 563-564.
75. Mansourian, A.R., E.O. Ghaemi, A.R. Ahmadi, A. Saifi, A.V. Moradi and S. Bakhshandeh-Nosrat, 2007. A survey of urinary iodine concentration in South-East of Caspian Sea inNorthern, Iran. Pak. J. Biol. Sci., 10: 2166-2171.
76. Mansourian, A.R., E.O. Ghaemi, A. Ahmadi, A. Marjani, A. Saifi and S. Bakhshandehnosrat, 2008. Serum lipid level alteration in sub clinical hypothyroid patients in Gorgan (South East Caspian Sea). J. Chinese Clin. Med., 3: 206-210.
77. Mansourian, A.R., 2010a. A review on post-puberty hypothyroidism: A glance atmyxedema. Pak. J. Biol. Sci., 13: 866-876.
78. Mansourian, A.R., 2010b. The immune system which adversely alter thyroid functions: A review on the concept of autoimmunity. Pak. J. Biol. Sci., 13: 765-774.
79. Mansourian, A.R., 2010c. The state of serum lipids profiles in sub-clinical hypothyroidism: A review of the literature. Pak. J. Biol. Sci., 13: 556-562.
80. Mansourian, A.R., 2010d. Thyroid function tests during first-trimester of pregnancy: A review of literature. Pak. J. Biol. Sci., 13: 664-673.
81. Mansourian, A.R., A.R. Ahmadi, A. Saifi and S. Bakhshandehnosrat, 2010a. The childeren reference range of thyroid hormones in Northern Iran. Pak. J. Biol. Sci., 13: 862-865.
82. Mansourian, A.R., A.R. Ahmadi, H.R. Mansourian, A. Saifi, A. Marjani, G.R. Veghari and E. Ghaemi, 2010b. Maternal thyroid stimulating hormone level during the first trimester of pregnancy at the South-East of the Caspian sea in IRAN. J. Clin. Diagnostic Res., 4: 2472-2477.
83. Many, M.C., C. Mestdagh, M.F. Van den Hove and J.F. Denef, 1992. In vitro study if acute toxic effects of high iodide dosis in human thyroid follicles. Endocrinology, 131: 621-630.
84. Marine, D., 1924. Etiology and prevention of simple goiter. Medicine, 3: 453-462.
85. Mariotti, S. and A. Pinchera, 1990. Role of the Immune System in the Control of Thyroid Function. In: The Thyroid Gland, Greer, M.A., (Ed.). Raven Press Ltd., New York, pp: 147.
86. Mariotti, S., E. Martino, C. Cuppini, R. lari, C. Giani, L. Baschieri and A. Pinchera, 1982. Low serum thryogolobulin as a clue to the diagnosis of thyrotoxicosis factitia. N. Engl. J. Med., 307: 410-412.
87. Mariotti, S., E. Martino, M. Francesconi, C. Ceccarelli, L. Grasso. F. Lippt, L. Baschieri and A. Pinchera, 1986. Serum thyroid auto antibodies as a risk factor for development of hypothyroidism after radioactive iodine therapy for single thyroid hot nodule. Acta Endocrinol, 113: 500-507.
88. Marjani, A.R., A.R. Mansourian, E.O. Ghaemi, A. Aahmadi and V. Khori, 2008. Lipidperoxidation in serum of hypothyroid patients (In Gorgan South East of Caspian Sea). Asian J. Cell Biol, 3: 47-50.
89. Martin, F.I., B.W. Tress, P.G. Colman and D.R. Deam, 1993. Iodine-induced hyperthyroidism due to nonionic contrast radiography in the eldery. Am. J. Med., 95: 78-82.
90. Matrino, E., F. Aghini-Lombardi, L. Bartalena, L. Grasso and A. Loviselli et al., 1994. Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease. Arch. Int. Med., 154: 2722-2726.
91. Mazson, P.D., M.L.Williams, L.K. Cantley, F.G. Dalldorf, R.D. Utiger and J.R. Foster, 1984. Myxedema coma long term amiodarone therapy. Am. J. Med., 77: 751-754.
92. Mazzaferri, E.L., 1990. Thyroid cancer and graves disease. J. Clin. Endocrinol. Metab., 70: 826-829.
93. McDermott, M.T. and E.C. Ridgway, 1998. Central hyperthyroidism. Endocrinol. Metab. Clin. North Am., 27: 187-203.
94. Misra, M., L.L. Levitsky and M.M. Lee, 2002. Transient hyperthyroidism in an adolescent with hydatidiform mole. J. Pediatr., 140: 362-366.
95. Miyakawa, M., T. Tsushima, N. Onoda, M. Etoh and O. lsozaki et al., 1992. Thyroid ultrasonography related to clinical and laboratory finding in patings in patients with silent thyroiditis. J. Endocrinol. Invest., 15: 289-295.
96. Nakashima, T., K. Enue, A. Shireo-osu, M. Yoshinari, K. Okamura and M. ltoh, 1981. Predominant T3 synthesis in the metastatic thyroid carcinoma in a patient with T3 toxicosis. Metabolism, 30: 327-330.
97. Nayak, B. and K. Burman, 2006. Thyrotoxicosis and thyroid storm. Endocrinol. Metab. Clin. North Am., 35: 663-686.
98. Neumann, S., H. Willgerodt, F. Ackermann, A. Reske, M. Jung, A. Reis and R. Paschke, 1999. Linkage of familial euthyroidgoiter to the multinodular goiter-1 locus and exclusion of thecandidategenes, thyroglobulin, thyroperoxidase andNa/1 -symporter. J. Clin. Endocrmol. Metab., 84: 3750-3756.
99. Nogueira, C.R., P. Kopp, O.K. Arseven, C.L. Stantos, J.L. Jameson and G. Madeiros-Neto, 1999. Thyrotropin receptor mutations in hyperfunctioning adenomas from Brazil. Thyroid, 9: 1063-1068.
100. O'Brien, T., K. Katz and D. Hodge, 1997. Effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins Al, All and E. Clin. Endocrmol., 46: 17-20.
101. Orgiazzi, J., B. Rousset, C. Cosentino, J. Tourniere and N. Dutrieux, 1974. Plasma thyrotropic activity in a man with choriocarcinoma. J. Clin. Endocrinol. Metab., 39: 653-657.
102. Orgiazzi, J.J. and R. Moniex, 1990. Hyperthroidism. In: The Thyroid Gland, Greer, M.A. (Ed.). Raven Press, New York, pp: 442.
103. Ouchimoura, H., S. Nagayaki, K, Ito, S.M. Amir and S.H. Ingbar, 1982. Inhibition of the thyroid adenylate cyclase response to thyroid stimulating immunoglobulin G and asiab human chorionic gonadotropin. J. Clin. Endocrinol. Metab., 55: 374-377.
104. Paima, J., J. Van Sande, S. Swillens, M. Tonacchera, J. Dumont and G. Vassart, 1995. Somatic mutations causing constitutive activation of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas identification of additional mutatuins activating both the cyclic adenosine 3,5-monophosphate and inositol phosphate CA2+ vascades. Mol. Endocrinol., 9: 725-733.
105. Paima, J., L. Duperz, J. Van Sande, J. Hermans and P. Rocmans et al, 1997. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as cause of toxic thyroid ademona. J. Clin. Endocnnal. Metab., 52: 2695-2701.
106. Paul, SJ. and J.C. Sisson, 1990. Thyrotoxicosis caused by thyroid cancer. Endocrinol. Metab. Clin. North Am., 19: 593-612.
107. Persani, L., A. Lania, L. Alberti, R Romoli and G. Mantovanj et al, 2000. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas. J. Clin. Endocrinol. Metab., 85: 2872-2878.
108. Peter, H. J., H. Gerber, H. Stunder and S. Smeds, 1985. Pathogenesis ofhetrogenity in human multinodular goiter. J. Clin. Invest., 76: 1992-2002.
109. Pinducciu, C, G. Borgonovo, A. Arezzo, G.C. Torre, G. Giordano and R. Cordera, 1998. Toxic thyroid adenoma absence of DNA mutations of the TSH receptor and Gs alpha. Eur. J. Endocrional., 138: 37-40.
110. Polak, M., J. Bertherat and J.Y. Li et al, 1991. A human TSH-secreting adenoma: Endocrine biochemical and morphological studies. Evidence of somatostatin receptotors by using quanitative autiradiography. Clinical and biological improvement by SMS 201-995 treatment. Acta Endocrinol, 1224: 479-486.
111. Ratcliffe, G.E., S. Cooke, I. Fogelman and M.N. Maisey, 1986. Radioiodine treatment of solitaty functioning thyroid nodules. Br. J. Radiol., 59: 385-387.
112. Rodien, P., C. Bremont, M.L.R. Sanson, J. Parma and J. Van Sande et al., 1998. Familia gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N. Engl. J. Med., 339: 1823-1826.
113. Ross, D.S., E.C. Ridgway and G.H. Daniels, 1984. Successful treatment of solitary toxic nodules with relatively low dose 1131 with low prevalence of hypothyroidism. Ann. Int. Med., 101: 488-490.
114. Sandier, M.B., B. Fellmeth, K.E. Salhany and J.A. Patton, 1998. Thyroid carcinoma masquerading as a solitary benign hyperfunctioning nodule. Clin. Nucl. Med., 13: 410-415.
115. Sanno, N., A. Teramoto and R.Y. Osamura, 2001. Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment. J.Nerurooncol., 54: 179-186.
116. Schneeberg, N.G., 1983. Silent thyroiditis. Arch. Intern. Med., 143: 2214-2214.
117. Sergi, E., G. Medri, M.J. Papandreou, G. Gunz, P. Jaquet and C. Ronin, 1993. Polymorphism of thyrotropin and alpha subunit in human pituitary adenomas. J. Endocrinol. Invest., 16: 45-55.
118. Shahmohammdi, F., A.R. Mansourian and H.R Mansourian, 2008. Serum thyroid hormone level in women with nausea and vomiting in early pregnancy. J. Medical Sci., 8: 507-510.
119. Shapiro, L.E., R. Sievert, L. Ong, E.L. Ocampo and R.A. Chance et al., 1997. Minimal cardiac effects in asymptomatic athyreotic patients chronically trated with thyrotropin suppressive doses of L-thyroxine. J. Clin. Endocrinol. Metab., 82: 2592-2595.
120. Shimatsu, A., H. Murabe, K. Kamoi, Y. Susuki and K. Nakao, 1999. Treatment of thyroptropin secreting pituitary ademomas with octreotide. Endocr. J., 46: 113-123.
121. Simkin, P.H., L.A. Ramirez, S.L. Zwezig, S.A. Alfonso and A.E. Fraire et al, 1999. Monomprophic teratoma of the overy: A rare cause of triiodothyronine toxicosis. Thyroid, 9: 949-954.
122. Smallndge, R.C. and C.E. Smith, 1983. Hypethyroidism due to thyrotropin secretine pituitary tumars Diagnostic and therapeutic considerations. Arch. Int. Med., 143: 503-507.
123. Smits, G., C. Govaerts, I. Nubourgh, L. Pardo, G. Vassart and S. Costagliola, 2002. Lysine 183 and glutamic acid 157 of the TSH receptor: Two interacting residues with a key role in determining specificity toward TSH and human CG. Mol. Endocrinol., 16: 722-735.
124. Stanbury, J.B., A.E. Ermans, P. Bourdoux, C. Todd and E. Oken et aL, 1998. Iodine-induced hyperthyroidism: Occurrence and epidemiology. Thyroid, 8: 83-100.
125. Steffensen, F.H. and N. Aunsholt, 1994. Hyperthyroidism associated with metatatic thyroid carcinoma. Clin. Endocrinol, 41: 685-687.
126. Stewart, J.C. and G.I. Vidor, 1976. Thyrotoxicosis iduced by iodine contamination of food: A common unrecognized condition. Br. Med. J., 1: 372-375.
127. Streetman, D.D. and U. Khanderia, 2003. Diagnosis and treatment of Graves disease. Ann. Pharmacother., 37: 1100-1109.
128. Studer, H. and F. Ramelli, 1982. Simple goiter and its variants euthyroud and hyperthyroid multinodular goiters. Endorcr. Rev., 3: 40-61.
129. Studer, H., H. Gerber and HJ. Peter, 1989. Multinodular Goiter. In: Endocrinology, DeGroot, L.J. (Eds.). W.B. Saunders, Philadephia, pp: 722-723.
130. Symth, M., C. McHenry, H. Jarosz, A.M. Lawrence and E. Paloyan, 1988. Carcinoma of the thyroid in patients with automous nodules. Am. J. Surg., 54: 448-449.
131. Takeshita, A., Y. Nagayama, N. Yokoyama, N. Ishikawa and K. Ito et al., 1995. Rarity of oncogenic mutations in the throptropin receptor of autonomously functioning thyroid nodules in Japan. J. Clin. Endocrinal. Metab., 80: 2607-2611.
132. Taylor, ST., 1953. The evolution of nodular goiter. J. Clin. Endocrinol. Metab., 13: 1232-1247.
133. Thomas Jr., CG. and R.D. Croom 3rd, 1987. Current management of the patient with autonomously functionting nodular goiter. Surg. Clin. North Am., 67: 315-328.
134. Thome, S. A., I. Barnes, P. Cullinan and J. Somerville, 1999. Amiodarone-associated thyroid dysfunction: Risk factors in adults with congenital heart disease. Circulation, 100: 149-154.
135. Tolls, G., C. Bird, G. Bertrand, J.M. Mckenzie and C. Azrin, 1978. Pituitary hyperthyroidism. Am. J. Med., 64: 177-181.
136. Tonachera, M., P. Agertti, V. Rosellini, CG. Eccarini and A. Perri et al., 2000. Sporadic nonautoimmune congential hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene. Thyroid, 10: 895-863.
137. Trulzsch, B., K. krohn, P. wonerow, S. Chey, H.P. Holzapfel et al., 2001. Detection of thyroid-stimulating hormone receptor and Gaslpha multations: I 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J. Mol. Med., 78: 684-691.
138. Tzotzas, T., G.E. Krassas, T. Konstantindis and M. Bougoulia, 2000. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatments. Thyroid, 10: 8703-8708.
139. Vitug, A.C. and J.R. Goldman, 1985. Thyrotoxic silent thyroiditis a geographic puzzle. Arch. Intern. Med., 145: 2263-2264.
140. Wahner, H.W., C. Cuello, P. Correa, L.F. Uribe and E. Gaitan, 1966. Thyroid carcinoma in an endemic goiter area, Cali Colombia. Am. J. Med., 40: 58-66.
141. Yovos, J.G., J.M. Falko, T.M. O-Donsio, W.B. Marlakey, W.B.S. Cataland and C.C. Capen, 1981. Thyrotoxicosis and a thyrotropin -secreting pituitary tumor causing unilateral exophthalmos. J. Clin. Endocrinol. Metab., 53: 338-343.
142. Zalel, Y., D.S. Seidman, M. Oren, R Achiron, W. Gotheb, S. Ashiach and M. Goldenberg, 2000. Sonographic and clinical characteristics of struma ovarii. J. Ultrasound Med., 19: 857-861.